From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success
Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma,...
Category: In the News
Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma,...
A variety of national and local news outlets have highlighted AACR initiatives and experts in recent weeks. Learn about...
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers....
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
Two years ago, amid increased awareness of the need to diversify the scientific work force and end cancer health...